AASV Foundation-funded Report Available: Evaluating the Plasma Pharmacokinetics, Efficacy and Tissue Residues of Oral Firocoxib Following Transmammary Delivery from Sows to Piglets
March 2, 2020 —
The American Association of Swine Veterinarians Foundation (AASVF) funded a project, "Evaluating the plasma pharmacokinetics, efficacy and tissue residues of oral firocoxib following transmammary delivery from sows to piglets," led by Dr Hans Coetzee from Kansas State University. The objectives of the study were to describe the pharmacokinetics (PK) and bioavailability of oral firocoxib in sows, develop and validate a drug regimen for transmammary delivery of oral firocoxib from sows to piglets at processing, and describe the tissue residue concentrations of firocoxib in sows and piglets following oral administration. The final report with detailed findings is available on the AASV Foundation-funded Research page, or view the report directly.
- Next story: USDA Expands Laboratory Capabilities to Test for African Swine Fever
- Next in category: 2020 AWARRD Recipients Seek Answers on PRRS, Mhp
- Previous in category: Application Period Now Open for Boehringer Ingelheim Research Awards on Porcine Respiratory Diseases
- Previous story: People on the Move: Dr. Steve Larsen